Biotechnology company
Appears in 1 story · Last updated Sep 21, 2026
As of September 2026: Holder of the marketing authorization application for Zeydovio
Zealand Pharma's Zeydovio is one step from market in Europe. On September 17, the European Medicines Agency's scientific committee recommended approving the twice-weekly injection for adults with short bowel syndrome.
Updated Sep 20
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
